Pharmafile Logo
Pharmafocus logo
Advanced Search

Lilly’s first-in-class diabetes drug approved in US

May 5, 2005
Sales and Marketing

Lilly has gained US marketing approval for Byetta, the first in a new class of type II diabetes treatments derived …

News

Mixed news for AstraZeneca’s stroke drug Cerovive

May 4, 2005
Research and Development, Sales and Marketing

AstraZeneca has received a boost from its phase III drug Cerovive, with clinical trial data showing the treatment can reduce …

News

Does your brand need a check-up?

May 4, 2005
Sales and Marketing

Brands are all about 'adding value'. To provide this value to our target customers we need to ensure we have …

Feature

Filling in the gaps in your team

May 4, 2005
Business Services

Outsourcing as an integral element of a business strategy has waxed and waned in popularity and acceptability over the last …

Feature

Taking on the market leader

May 4, 2005
Sales and Marketing

Launching a new product into a therapeutic area dominated by a 'gold standard' doctors' favourite is a tough task but …

Feature

Velcade moves up to second line treatment

April 28, 2005
Sales and Marketing

Ortho Biotech's Velcade has received approval as a second-line treatment for patients with multiple myeloma in Europe, advancing it from …

News

EMEA advises against prescribing of antidepressants in children

April 28, 2005
Sales and Marketing

Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …

News

Cholesterol drugs boost Schering-Plough

April 26, 2005
Sales and Marketing

News

Strattera sales fall back over continuing safety concerns

April 26, 2005
Sales and Marketing

Lilly say it expects sales of Strattera to fall in 2005 because of continuing concerns over the safety of ADHD …

News

Woolley Pau wins Novo Nordisk insulin accounts

April 26, 2005
Medical Communications

Following a four-way pitch, Convent Garden-based advertising agency Woolley Pau has been appointed by Novo Nordisk to work on its …

News

MHRA failing patients, warns report

April 26, 2005
Sales and Marketing

MPs have called for an urgent review of the UK drugs regulator, saying that tougher regulation of the industry is …

News

Government promotes generic switch from GSK’s Lamictal

April 26, 2005

News

Super surgeries become an election issue

April 26, 2005

Labour plans to create 'super surgeries' designed to grant "entrepreneurial" GPs the opportunity to broaden their scope and offer patients …

News

Bextra withdrawal dents Pfizer’s sales juggernaut

April 22, 2005
Sales and Marketing

The suspension and withdrawal of Pfizer's Cox-II inhibitor Bextra has forced the company to cut its profit forecast for 2005, …

News

PCT mergers won’t solve financial problems, warns report

April 19, 2005

PCT mergers are unlikely to relieve the burden of financial pressures, according to a major report by the NHS Alliance.The …

News

US court rules in favour of Lilly’s Zyprexa

April 18, 2005
Sales and Marketing

Lilly's US patent on blockbuster antipsychotic drug Zyprexa (olanzapine) has been upheld, after a Supreme Court ruled against its generic …

News

Labour makes clinical trials law a manifesto pledge

April 15, 2005
Research and Development

The Labour party has promised to introduce new legislation which would oblige pharmaceutical companies to publish clinical trial data for …

News

Conservatives promise to scrap Strategic Health Authorities and A&E targets

April 14, 2005

News

Novartis signs respiratory deal with UK biotech companies

April 14, 2005
Research and Development

Novartis has signed a deal with two UK biotech companies to develop and market a new treatment for chronic obstructive …

News

Ogilvy reshuffle sweetens Healthworld

April 14, 2005
Medical Communications

The new Ogilvy Healthworld Advertising agency has been launched in the UK following a re-organisation at media communications giant WPP.The …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026